A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome

BACKGROUND & AIMS: Development of new and more effective therapies against hepatitis B virus (HBV) is limited by the lack of suitable small animal models. The HBV transgenic mouse model containing an integrated overlength 1.3-mer construct has yielded crucial insights, but this model unfortunate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JHEP Rep
Autors principals: Kruse, Robert L., Barzi, Mercedes, Legras, Xavier, Pankowicz, Francis P., Furey, Nika, Liao, Lan, Xu, Janming, Bissig-Choisat, Beatrice, Slagle, Betty L., Bissig, Karl-Dimiter
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940981/
https://ncbi.nlm.nih.gov/pubmed/33733079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100252
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars